Australis Capital Inc
F:AC4
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Australis Capital Inc
F:AC4
|
US |
|
A
|
Appili Therapeutics Inc
OTC:APLIF
|
CA |
|
V
|
Vilkyskiu Pienine AB
XMUN:UDW
|
LT |
|
Aozora Bank Ltd
F:AON
|
JP |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is AC4's stock price target?
Not Available
AC4 does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Australis Capital Inc?
Projected CAGR
-77%
The compound annual growth rate for Revenue over the next 1 year is -77%.